Upregulation of iASPP ameliorates hypoxia/reoxygenation-induced apoptosis and oxidative stress in cardiomyocytes by upregulating Nrf2 signaling

J Biochem Mol Toxicol. 2021 Mar;35(3):e22686. doi: 10.1002/jbt.22686. Epub 2020 Dec 17.

Abstract

The inhibitor of apoptosis-stimulating protein of p53 (iASPP) acts as a key modulator of cellular protection against oxidative stress. In the present work, we assessed the role of iASPP in the regulation of cardiomyocyte injury induced by hypoxia/reoxygenation (H/R). We found that H/R-exposed cardiomyocytes expressed decreased levels of iASPP. The upregulation of iASPP repressed H/R-induced injury by decreasing levels of apoptosis and reactive oxygen species production. The upregulation of iASPP increased nuclear factor (erythroid-derived 2)-like 2 (Nrf2) nuclear translocation and enhanced Nrf2 activation. The overexpression of Kelch-like ECH-associated protein 1 reversed iASPP-mediated promotion of Nrf2 activation. Nrf2 inhibition abrogated iASPP-mediated cardioprotective effects in H/R-exposed cardiomyocytes. Our work demonstrates that the upregulation of iASPP ameliorates H/R-induced apoptosis and oxidative stress in cardiomyocytes via potentiating Nrf2 signaling via modulation of Keap1.

Keywords: Keap1; Nrf2; iASPP; myocardial infarction; oxidative stress.

MeSH terms

  • Animals
  • Apoptosis*
  • Cell Line
  • Intracellular Signaling Peptides and Proteins / biosynthesis*
  • Mice
  • Myocardial Reperfusion Injury / metabolism*
  • Myocardial Reperfusion Injury / pathology
  • Myocytes, Cardiac / metabolism*
  • Myocytes, Cardiac / pathology
  • NF-E2-Related Factor 2 / metabolism*
  • Oxidative Stress*
  • Repressor Proteins / biosynthesis*
  • Signal Transduction*
  • Up-Regulation*

Substances

  • Intracellular Signaling Peptides and Proteins
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • Ppp1r13l protein, mouse
  • Repressor Proteins